Home › Companies › Insmed Incorporated › 2025-2026

Insmed Incorporated 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Insmed Incorporated’s Form 8-K, filed May 15, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

4Ballot items
629Asset managers
3,724Fund votes
May 13, 2026Meeting date

Results at a glance

Meeting of May 13, 2026: 4 items on Insmed Incorporated’s Form 8-K, filed May 15, 2026: 2 approved · 2 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Insmed Incorporated in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Insmed Incorporated

These tallies are Insmed Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Insmed Incorporated — official shareholder meeting results, meeting held May 13, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Elizabeth McKee Anderson	153,734,471	--	--	32,130,980	11,564,082	83%	Not verified	—
Elect Director: Clarissa Desjardins, Ph.D.	164,437,828	--	--	21,427,623	11,564,082	88%	Not verified	—
2. Advisory Vote on the 2025 Compensation of Named Executive Officers	162,133,728	23,657,325	74,398	--	11,564,082	87%	Approved	—
3. Ratification of the Appointment of an Independent Registered Public Accounting Firm	190,386,612	6,997,613	45,308	--	--	96%	Approved	—

Source: Insmed Incorporated, Form 8-K, filed with the SEC on May 15, 2026 — read the filing on EDGAR.

How asset managers voted at the Insmed Incorporated 2025-2026 meeting

Each item below shows how the 629 asset managers that disclosed a Insmed Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Clarissa Desjardins, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 12 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%

FOR: 164,437,828WITHHELD: 21,427,623

Details: description as filed, official tally, votes by 155 asset managers

Description as filed by funds: Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.

Insmed Incorporated’s own tally for this item (“Elect Director: Clarissa Desjardins, Ph.D.”): 164,437,828 for, 21,427,623 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 83,945,510 for, 2,847,814 withheld, 17,266 abstained, 163 not voted.

FOR

FOR: 83,945,510ABSTAIN: 17,266WITHHOLD: 2,847,814NOT VOTED: 163

Largest asset managers voting on “Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the” at Insmed Incorporated, 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	20,079,762	90	0	For
JPMorgan	14,732,012	0	0	For
Fidelity	13,606,000	0	0	For
Invesco	6,247,157	0	0	For
BlackRock	5,850,807	0	0	For
Capital Group	4,716,397	0	0	For
T. Rowe Price	0	0	2,221,489	Withhold
Columbia Threadneedle	1,946,885	0	0	For
Charles Schwab	1,013,492	0	0	For
Franklin Custodian Funds	850,000	0	0	For
Bridge Builder Trust	777,196	0	0	For
FRANKLIN STRATEGIC SERIES	687,831	0	0	For
American Century	680,542	0	0	For
Waddell & Reed	657,272	0	0	For
Jackson National	650,188	0	0	For
State Street	606,348	0	0	For
MUTUAL FUND SERIES TRUST	551,328	0	0	For
Victory Capital	519,578	0	0	For
Equitable	327,172	0	178,413	Mixed
CARILLON SERIES TRUST	500,953	0	0	For
TIAA	471,703	0	0	For
Lord Abbett	452,286	0	0	For
Principal	412,285	0	0	For
Federated Hermes	374,598	0	0	For
Manager Directed Portfolios	352,531	0	0	For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

2. Elect Director: Elizabeth McKee Anderson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 13 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD

FOR: 153,734,471WITHHELD: 32,130,980

Details: description as filed, official tally, votes by 155 asset managers

Insmed Incorporated’s own tally for this item (“Elect Director: Elizabeth McKee Anderson”): 153,734,471 for, 32,130,980 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 82,965,811 for, 3,759,756 withheld, 85,023 abstained, 163 not voted.

FOR

FOR: 82,965,811ABSTAIN: 85,023WITHHOLD: 3,759,756NOT VOTED: 163

Largest asset managers voting on “Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the” at Insmed Incorporated, 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	20,062,833	128	16,891	For
JPMorgan	14,732,012	0	0	For
Fidelity	13,606,000	0	0	For
Invesco	6,247,157	0	0	For
BlackRock	5,850,807	0	0	For
Capital Group	4,716,397	0	0	For
T. Rowe Price	0	0	2,221,489	Withhold
Columbia Threadneedle	1,946,885	0	0	For
Charles Schwab	1,013,492	0	0	For
Franklin Custodian Funds	850,000	0	0	For
Bridge Builder Trust	777,196	0	0	For
FRANKLIN STRATEGIC SERIES	687,831	0	0	For
American Century	680,542	0	0	For
Waddell & Reed	657,272	0	0	For
Jackson National	647,765	2,423	0	For
State Street	1,752	0	604,596	Withhold
MUTUAL FUND SERIES TRUST	551,328	0	0	For
Victory Capital	519,578	0	0	For
Equitable	327,172	0	178,413	Mixed
CARILLON SERIES TRUST	500,953	0	0	For
TIAA	471,703	0	0	For
Lord Abbett	452,286	0	0	For
Principal	412,285	0	0	For
Federated Hermes	374,598	0	0	For
Manager Directed Portfolios	352,531	0	0	For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

3. 2. Advisory Vote on the 2025 Compensation of Named Executive Officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

87% Approved · of votes cast

FOR 87%

FOR: 162,133,728AGAINST: 23,657,325

Details: description as filed, official tally, votes by 628 asset managers

Description as filed by funds: An advisory vote on the 2025 compensation of our named executive officers.

Insmed Incorporated’s own tally for this item (“2. Advisory Vote on the 2025 Compensation of Named Executive Officers”): 162,133,728 for, 23,657,325 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 152 asset managers voting on “An advisory vote on the 2025 compensation of our named executive officers.” at Insmed Incorporated, 2025-2026
Asset manager	For	Against	Vote
Vanguard	20,079,755	96	For
JPMorgan	14,732,012	0	For
Fidelity	13,606,000	0	For
Invesco	6,247,157	0	For
BlackRock	5,850,807	0	For
Capital Group	4,716,397	0	For
T. Rowe Price	1,930,814	290,675	Mixed
Columbia Threadneedle	1,946,885	0	For
Charles Schwab	1,013,492	0	For
Franklin Custodian Funds	850,000	0	For
Bridge Builder Trust	777,196	0	For
FRANKLIN STRATEGIC SERIES	687,831	0	For
American Century	680,542	0	For
Waddell & Reed	657,272	0	For
Jackson National	650,188	0	For
State Street	606,348	0	For
MUTUAL FUND SERIES TRUST	551,328	0	For
Victory Capital	519,578	0	For
Equitable	505,585	0	For
CARILLON SERIES TRUST	500,953	0	For
TIAA	471,703	0	For
Lord Abbett	452,286	0	For
Principal	412,285	0	For
Federated Hermes	374,598	0	For
Manager Directed Portfolios	352,531	0	For

Fund voting reports, all 152 managers: 86,404,525 for, 404,274 against, 6,647 abstained, 163 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 514 asset managers voting on “An advisory vote on the 2025 compensation of our named executive officers.” at Insmed Incorporated, 2025-2026
Asset manager	For	Against	Vote
Darwin Global Management, Ltd.	0	17,163,874	Against
Fidelity	12,368,145	703,849	Mixed
BlackRock	7,746,889	44	For
Invesco	7,051,550	0	For
Artisan	5,369,463	0	For
RTW INVESTMENTS, LP	4,842,880	0	For
Capital Group	4,818,897	0	For
GEODE CAPITAL MANAGEMENT, LLC	4,412,370	0	For
State Street	3,765,719	0	For
T. Rowe Price	2,978,517	418,885	Mixed
Orbis Allan Gray Ltd	2,605,782	0	For
FRANKLIN ADVISERS INC	2,400,080	0	For
DE Shaw	1,720,005	0	For
Vanguard	1,641,633	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	1,176,583	0	For
Charles Schwab	1,134,043	0	For
Northern Trust	1,109,267	0	For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST	1,076,813	0	For
Duquesne Family Office LLC	1,008,266	0	For
Amundi	0	992,373	Against
Castle Hook Partners LP	908,452	0	For
PICTET ASSET MANAGEMENT SA	876,466	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	851,855	0	For
AMERIPRISE FINANCIAL INC	799,269	0	For
Paradigm Biocapital Advisors LP	778,118	0	For

Institutional-manager reports, all 514 managers: 98,922,440 for, 22,928,312 against, 5,583 abstained, 6,741 not voted. Showing the 25 largest; see all in the interactive database.

4. 3. Ratification of the Appointment of an Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%

FOR: 190,386,612AGAINST: 6,997,613

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.

Insmed Incorporated’s own tally for this item (“3. Ratification of the Appointment of an Independent Registered Public Accounting Firm”): 190,386,612 for, 6,997,613 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 86,580,862 for, 167,782 against, 6,647 abstained, 163 not voted.

FOR

FOR: 86,580,862AGAINST: 167,782ABSTAIN: 6,647NOT VOTED: 163

Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at Insmed Incorporated, 2025-2026
Asset manager	For	Against	Vote
Vanguard	20,062,933	16,918	For
JPMorgan	14,732,012	0	For
Fidelity	13,606,000	0	For
Invesco	6,247,157	0	For
BlackRock	5,850,807	0	For
Capital Group	4,716,397	0	For
T. Rowe Price	2,221,489	0	For
Columbia Threadneedle	1,946,885	0	For
Charles Schwab	1,013,492	0	For
Franklin Custodian Funds	850,000	0	For
Bridge Builder Trust	777,196	0	For
FRANKLIN STRATEGIC SERIES	687,831	0	For
American Century	680,542	0	For
Waddell & Reed	657,272	0	For
Jackson National	650,188	0	For
State Street	606,327	21	For
MUTUAL FUND SERIES TRUST	551,328	0	For
Victory Capital	519,578	0	For
Equitable	505,585	0	For
CARILLON SERIES TRUST	500,953	0	For
TIAA	471,703	0	For
Lord Abbett	452,286	0	For
Principal	412,285	0	For
Federated Hermes	374,598	0	For
Manager Directed Portfolios	352,531	0	For

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Largest Insmed Incorporated shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 216,521,841 shares outstanding at the time of that meeting.

Fund voting reports: top Insmed Incorporated shareholders by shares voted on “An advisory vote on the 2025 compensation of our named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	9.27%
2	JPMorgan	6.80%
3	Fidelity	6.28%
4	Invesco	2.89%
5	BlackRock	2.70%
6	Capital Group	2.18%
7	T. Rowe Price	1.03%
8	Columbia Threadneedle	0.90%
9	Charles Schwab	0.47%
10	Franklin Custodian Funds	0.39%

Institutional-manager reports: top Insmed Incorporated shareholders by shares voted on “An advisory vote on the 2025 compensation of our named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	Darwin Global Management, Ltd.	7.93%
2	Fidelity	6.04%
3	BlackRock	3.58%
4	Invesco	3.26%
5	Artisan	2.48%
6	RTW INVESTMENTS, LP	2.24%
7	Capital Group	2.23%
8	GEODE CAPITAL MANAGEMENT, LLC	2.04%
9	State Street	1.74%
10	T. Rowe Price	1.57%

Reported Insmed Incorporated holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Insmed Incorporated holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
JPMorgan Chase	11.15%	13F
Vanguard Group	9.73%	13F
BlackRock	7.70%	13F
FMR (Fidelity)	6.08%	13F
Darwin Global Management, Ltd.	2.97%	13G
D.E. Shaw	2.61%	13F
State Street	2.56%	13F
T. Rowe Price	1.43%	13F
Franklin Templeton	1.21%	13F

Percentages above are of 216,521,841 shares outstanding, as reported by Insmed Incorporated on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Insmed Incorporated’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Insmed Incorporated's shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 629 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 3,724 separate fund positions. On the most widely held item on that ballot — An advisory vote on the 2025 compensation of our named executive officers. — Insmed Incorporated's filing reports the proposal as approved, with 87% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Insmed Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2026.

Insmed Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.